Tag : genome sequencing

Samuel Levy to continue as Chief Scientific Officer Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy...

Collaboration will transform new insights into drug discovery and therapy development through large-scale genomics Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt...

Pfizer Inc. (NYSE: PFE) and Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced an exclusive four-year research collaboration focused...

Initiated Expansion Cohort of SY-5609 with Chemotherapy in Pancreatic Cancer Patients Expects to Report Data from Three Clinical Trials Across Hematology and Selective CDK Inhibitor...

Phase Genomics announces OncoTerra™, its new research use only (RUO) cancer genomics platform leveraging ultra-long-range sequencing technology Phase Genomics, Inc., a biotech company leading advancements...

Management to share updates on company’s non-invasive cancer detection programs Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation...

Partnership will Accelerate Next-Generation Sequencing into Fastest-Growing Area of Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow Illumina, Inc. (NASDAQ: ILMN) today announced it has entered...

Helix has announced three new executive placements as the company rapidly expands its population genomics and viral surveillance offerings into a broader set of health systems,...

Dr. Yeu brings her deep knowledge in ophthalmology and the latest industry innovations to further accelerate Avellino’s ophthalmic research and product pipeline Avellino Lab USA,...

The GeneASIC Next-Generation Sequencing Analysis Acceleration Platform will make its debut to accelerate genome sequencing in early intervention.  GeneASIC Technologies will be walking into this year’s...